K K Schmiegel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

K K Schmiegel

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Immunological Methods|August 22, 1997

Competitive particle concentration fluorescence immunoassays for measuring anti-diabetic drug levels in mouse plasmaS W Bright, F C Tinsley, S J Dominianni, et al.

Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1991

Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic miceT T Yen, K K Schmiegel, G Gold, et al.

Life Sciences|January 1, 1997

Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivityS W Bright, G Gold, S W Sage, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Immunological Methods|August 22, 1997

Competitive particle concentration fluorescence immunoassays for measuring anti-diabetic drug levels in mouse plasmaS W Bright, F C Tinsley, S J Dominianni, et al.

Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1991

Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic miceT T Yen, K K Schmiegel, G Gold, et al.

Life Sciences|January 1, 1997

Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivityS W Bright, G Gold, S W Sage, et al.

Pageof 1